Clinical Trials
48 trialsCASCADE
University of Basel
SJFAMILY
St. Jude Children's Research Hospital
Pediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
BWHS RoR
Boston University
FIMBRIECTOMIE
Centre Oscar Lambret
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
M.D. Anderson Cancer Center
HCP
University of Southern California
Identifying and Caring for Individuals With Inherited Cancer Syndrome
OHSU Knight Cancer Institute
CHARM1
University Health Network, Toronto
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Abramson Cancer Center at Penn Medicine
Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations
M.D. Anderson Cancer Center
CHARM2
University Health Network, Toronto
Reborn-i
Beaumont Hospital
PROGECT
University of Kansas Medical Center
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Georgetown University
CHARM
Kaiser Permanente
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Georgetown University
Women at Risk of Breast Cancer and OLFM4
Institut Cancerologie de l'Ouest
PC-CDS
HealthPartners Institute
Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study
Ohio State University Comprehensive Cancer Center
Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands
Peking University Third Hospital
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Northwestern University
TUMOSPEC
UNICANCER
Gene-HEART
Abramson Cancer Center at Penn Medicine
DIRECT
Umeå University
LIBER
UNICANCER
LIBRE
Technical University of Munich
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Washington University School of Medicine
LIBRE-2
Technical University of Munich
BRCA-HRT
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Enhance the Use of Genetic Counseling and Testing in Latinas
Georgetown University
Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment
Georgetown University
Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk
Centre Jean Perrin
Statewide Communication to Reach Diverse Low Income Women
University of California, San Francisco
Tissue Expansion in Breast Reconstruction Without Drains
Cedars-Sinai Medical Center
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
Georgetown University
Genetic Counseling for Breast Cancer Survivors (GC for BC)
H. Lee Moffitt Cancer Center and Research Institute
GENEPY
Institut Claudius Regaud
Genetic Risk: Whether, When, and How to Tell Adolescents
Johns Hopkins University
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
Peking Union Medical College Hospital
Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
Emory University
Risk-Reducing Surgeries for Hereditary Ovarian Cancer
Peking Union Medical College Hospital
Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children
Georgetown University
Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)
M.D. Anderson Cancer Center
Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study
Medical University of Vienna
EXSAL
Centre Francois Baclesse
Telemedicine vs. Face-to-Face Cancer Genetic Counseling
Duke University
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
The Cleveland Clinic